Protection Effect of Dexamethasone on the Memory Impairment and Neuronal Damage of Neonate Rats that Repeatedly Suffered Sevoflurane Exposure
Abstract
To investigate the protection effect of dexamethasone (DXMS) on the memory impairment and neuronal damage of neonate rats that caused by sevoflurane (SEVO) exposure. Methods 5-days-old newborn SD rats were randomly divided into normal group (NC group) (10 rats), SEVO group (10 rats) and SEVO+DXMS group (10 rats). Rats of SEVO group and SEVO+DXMS group were exposed to 2.5% SEVO 2 h per day for 1 week, meanwhile the rats of SEVO+DXMS group were given 20 mg/kg DXMS treatment before exposure and the normal group was given the same amount of placebo and carrier gas as control. All rats were fed normally till infancy. Then the Morris water maze test was used to assess the learning and memory function of rats of each group. HE and Nissl staining were used to observe the histomorphology and neuronal changes in the hippocampus of rats. ELISA was performed to test the changes in nitric oxide (NO), superoxide dismutase (SOD) and malondialdehyde (MDA) level in brain tissues. The expression of silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), fork head protein transcription factor 3α (FOXO3α) mRNA in brain tissue was detected by qRT-PCR. Western blot was used to explore the changes in SIRT1 and caspase-3 protein expression of hippocampus. Results Compared with the NC group, the pathologic damage of hippocampus tissues was severely in SEVO group, and the number of neuronal cells was decreased as well. After SEVO intervention, the degree of pathologic damage was alleviated, and the number of neuronal cells was significantly increased. The Morris water maze test showed that the escape latency, number of platform crossing and target quadrant retention time between SEVO group and SEVO+DXMS group were significant different. The level of NO and MDA in brain of SEVO+DXMS group was significantly decreased than that of SEVO group, while the level of SOD was increased. qRT-PCR showed that the mRNA levels of SIRT1, PGC-1α and FOXO3α in SEVO+DXMS group were significantly higher those in SEVO group, but mRNA level of SIRT1 was still significantly lower than that of NC group. Western blot showed that the expression of SIRT1 protein in SEVO+DXMS group was significantly higher than that of SEVO group, and the expression of caspase-3 was reduced in SEVO+DXMS compared with SEVO group. Conclusion DXMS could reduce the level of oxidative stress and suppress the apoptosis of neuronal cells, reduce SEVO-induced brain damage in neonatal rats and improve learning and memory ability in infant rats.
Keywords: Dexamethasone, Sevoflurance, Memory impairment, Neuronal damage
Full Text:
PDFReferences
KARLSSON V. SPORRE В. AGREN J. Transcutaneous pco2 monitoring in newborn infants during general anesthesia is technically feasible. Anesth Analg.2016. 123 (4 ): 1004-
SOO К G, YANG M. CHANG С H, et al. Management of cardiac arrest in a parturient with Eisenmenger1 s syndrome and complete atrioventricular block during Cesarean section: a case repori. Korean J Aneslhesiol,2015,68(6) ;617-621.
CHAI J, WU X Y, HAN N, et al. A retrospective study of anesthesia during rigid bronchoscopy for airway foreign body removal in children; propofol and sevoflurane with spontaneous ventilation. Paediatr Anaesth, 2015, 24 ( 10 ); 1031-1036.
ZHANGS, HU X Y, GUAN W, et al. Isoflurane anesthesia promotes cognitive impairment by inducing expression of j3-amyloid protein-related factors in the hippocampus of aged rats. PLoS One. 12(4) :e0175654[2019- 3-18]. https;//doi. org/10. 1371/journal, pone. 0175654.
WEN X R, FU Y Y, LIU H Z, et al. Neuroprotection of sevoflurane against ischemia/reperfusion-induced brain injury through inhibiting jnk3/caspase-3 by enhancing akt signaling pathway. Mol Neurobiol,2016,53(3) ; 1661-1671.
FENG X, YUAN W. Dexamethasone enhanced functional recovery after sciatic nerve crush injury in rats. Biomed Res Int, 2015, 2015:627923. http://dx.doi.org/10. 1155/2015/ 627923.
ARSLAN M, ISIK В. KAVUTCU M, et al. Oxidative stress and antioxidant activity of female rat liver tissue after sevoflurane anaesthesia; Young versus old. Bratisl Lek Listy,2012,113(12):702-706.
ARSLAN M, OZKOSE Z, AKYOL G, et al. The age- and gender-dependent effects of desflurane and sevoflurane on rat liver. Exp Toxicol Pathol,2010,62( 1) ;35-43.
DIMAGGIO C, SUN L S, LI G . Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg, 2011, 113 (5):1143-1151.
KALAFATAKIS K, RUSSELL G M, ZARROS A, et al. Temporal control of glucocorticoid neurodynamics and its relevance for brain homeostasis, neuropathology and glucocorticoid-based therapeutics. Neurosci Biobehav Rev, 2016,61:12-25.
IQBAL M, BAELLO S, JAVAM M, et al. Regulation of multidrug resistance p-glycoprotein in the developing blood- brain barrier; interplay between glucocorticoids and cytokines. J Neuroendocrinol, 2015,28(3); 12360. https;// doi. org/10. 1111/jne. 12360.
D’HOOGE R, DE DEYN PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev,2001 ,36 (1):60-90.
GHOSH A, HIGHTON D. KOLYVA C, et al. Hyperoxia results in increased aerobic metabolism following acute brain injury. J Cereb Blood Flow Metab,2017,37(8) :2910-2920.
YAZICI T. KOCER G, NAZIROGLU M. et al. Zoledronic Acid. Bevacizumab and Dexamethasone-Induced Apoptosis. Mitochondrial Oxidative Stress, and Calcium Signaling Are Decreased in Human Osteoblast-Like Cell Line by Selenium Treatment. Biol Trace Elem Res,2018,184(2):358-368.
HE Y, ZHANG L, ZHU Z, et al. Blockade of cyclophilin D rescues dexamethasone-induced oxidative stress in gingival tissue. PLoS One, 2017, 12 (4): e0175616 [2019-07-11]. http://doi. org/10. 1371/journal, pone. 0173270.
LEEH, KIM M. PARK Y H, et al. Dexamethasone downregulates SIRT1 and IL6 and upregulates EDN1 genes in stem cells derived from gingivae via the AGE/RAGE pathway. Biotechnol Lett,2018,40(3) ;509-519.
VELLINGA T T, BOROVSKI T, DE BOER V C, et al. SIRTl/PGCla dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer. Clin Cancer Res,2015,21( 12) ;2870-2879.
KHAN S A, SATHYANARAYAN A, MASHEK M T, et al. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-la/PPAR-a signaling. Diabetes,2015,64(2);418-426.
TSAI M S, LEE P H, SUN С К, et al. Nerve growth factor upregulates sirtuin 1 expression in cholestasis; a potential therapeutic target. Exp Mol Med, 2018, 50 ( 1 ) ; e426. https;//www. nature. com/articles/emm2017235. doi; 10. 1038/emm. 2017.235.
Refbacks
- There are currently no refbacks.



